Highflying Biotech Stock Sets Up After 96% Pop; Annual Profit In Sight As Key Drug Sales Double

11/17/2025Find out which top-rated stocks have just earned a spot... BREAKING: Stocks Bounce But Tumble For Week Among big winners in the stock market this year, Alnylam Pharmaceuticals (ALNY) has climbed amid increasing uptake of its chief drug, Amvuttra. The stock did retreat from its all-time high of 495.55 in the wake of the company's strong third-quarter results. However, even after accounting for the recent pullback, the biotech stock has soared about 96% in 2025. Alnylam is… Related news Alnylam, Mon ...